NS · Pharmaceuticals

Divi's Laboratories Ltd (DIVISLAB)

Pharmaceuticals & Biotechnology

Divi's Laboratories Ltd (DIVISLAB) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $1.79T, P/E ratio is 68.75, net margin is 22.3%, dividend yield is 0.44%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for DIVISLAB

Market cap

$1.79T

P/E ratio

68.75

Net margin

22.3%

Dividend yield

0.44%

Divi's Laboratories Ltd (DIVISLAB) — FAQ

What is Divi's Laboratories Ltd's market cap?

Divi's Laboratories Ltd (DIVISLAB) has a reported market cap of $1.79T (data as of 2026-07-10).

What is DIVISLAB's P/E ratio?

The price-to-earnings (P/E) ratio for Divi's Laboratories Ltd (DIVISLAB) is 68.75 (data as of 2026-07-10).

Does Divi's Laboratories Ltd pay a dividend?

Divi's Laboratories Ltd (DIVISLAB) shows a reported dividend yield of 0.44%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Divi's Laboratories Ltd in?

Divi's Laboratories Ltd (DIVISLAB) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is DIVISLAB listed on?

DIVISLAB is listed on NS.

What is Divi's Laboratories Ltd's net margin?

Divi's Laboratories Ltd (DIVISLAB) reports a net margin of 22.3% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

FDC Ltd (FDC) Strides Pharma Science Ltd (STAR)